The current price of NTLA is $10.93 — it has decreased by 11.21% since the previous close. Data as of Nov 5, 2026.
NTLA is down 14.75% over the past week, down 13.88% over the past month and down 19.09% over the past year. The price is below its 200-day moving average of $13.07.
Intellia Therapeutics, Inc. has a market capitalization of $1.53B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
Companies most comparable to Intellia Therapeutics, Inc. include CRISPR Therapeutics AG, Beam Therapeutics Inc., Precigen, Inc., uniQure N.V. and MeiraGTx Holdings plc.
In the latest trading session NTLA moved between $10.89 and $12.19, a range of 11.94% of its current price.
Over the past 52 weeks NTLA has traded between $7.95 and $18.48. The current price is 40.85% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.